Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 2, 2000, Pages 337-343

  Buchholz, Thomas A ^a   Tucker, Susan L ^a   Moore, Richard A ^b   McNeese, Marsha D ^a   Strom, Eric A ^a   Jhingrin, Anuja ^a   Hortobagyi, Gabriel N ^a   Singletary, S Eva ^a   Champlin, Richard E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Breast cancer; High dose chemotherapy; Radiation; Transplant

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MESNA;

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; TREATMENT PLANNING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MASTECTOMY; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0033969583     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00429-0     Document Type: Article

References (21)

1. Antman K.H., Rowlings P.A., Vaughan W.P., et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol. 15:1997;1870-1879.
2. Peters W., Rosner G., Vredenburgh J., et al. A prospective randomized comparison of two doses of combination alkylating agents (AA) as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes (LN) Preliminary results of CALGB 9082/SWOG 9144/NCIC MA-13 . (Abstr) Proceed ASCO. 18:(1a):1999;2.
3. The Scandinavian Breast Study Group 9401. Results from a randomized adjuvant breast cancer study with high dose chemotherapy with CTCb supported by autologous bone marrow stem cells versus dose escalated and tailored FEC therapy (Abstr). Proceed ASCO 1999;18(1a):3.
4. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
5. Ragaz J, Jackson SM, Le N; et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-962.
6. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;547-581.
7. Gaynor J.J., Feuer E.J., Tan C.C., et al. On the use of cause-specific failure and conditional failure probabilities Examples from clinical oncology data . J Am Stat Assoc. 88:1993;400-409.
8. Cox DR, Oakes N. Analysis of survival data. New York: Chapman and Hall; 1988.
9. Recht A., Gray R., Davidson N.E., et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation Experience of the Eastern Cooperative Oncology Group . J Clin Oncol. 17:1999;1689-1700.
10. Wallgren A., Arner O., Bergström J., et al. Radiation therapy in operable breast cancer Results from the Stockholm trial on adjuvant radiotherapy . Int J Radiat Oncol Biol Phys. 2:1985;533-537.
11. Auquier A., Rutqvist L.E., Høst H., et al. Post-mastectomy megavoltage radiotherapy The Oslo and Stockholm Trials . Eur J Cancer. 28:1992;433-437.
12. Høst H., Brennhovd I.O., Loeb M. Postoperative radiotherapy in breast cancer Long-term results from the Oslo study . Int J Radiat Oncol Biol Phys. 12:1985;727-732.
13. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. N Engl J Med 1995;333:1444-1455.
14. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 12:1994;447-453.
15. Recht A., Bartelink H., Fourquet A., et al. Postmastectomy radiotherapy Questions for the twenty-first century . J Clin Oncol. 16:1998;2886-2889.
16. Diab S., Hilsenbec S.G., de Moor C., et al. Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy. J Clin Oncol. 16:1998;1655-1660.
17. Marks L.B., Halperin E.C., Prosnita L.R., et al. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥ 10 positive axillary lymph nodes. Int J Radiat Oncol Biol Phys. 23:1992;1021-1026.
18. Recht A., Come S.E. The optimal sequence of administration of radiation therapy and chemotherapy in patients with early and locally advanced breast cancer. Sem Breast Dis. 2:1999;135-144.
19. Buchholz T.A., Austin-Seymour M.M., Moe R.E., et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys. 26:1993;23-35.
20. Lara Jimenez P, Garcia Puche JL, Pedraza V. Adjuvant combined modality treatment in high risk breast cancer patients: Ten year results. 5th EORTC Breast Cancer Working Conference. Leuven, Belgium; 1991; A293.
21. Metz J.M., Schultz D.J., Fox K., et al. Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence. Cancer J Sci Am. 5:1999;77-83.